Immediately before the pandemic, the lateral flow test (LFT) market was already global, growing rapidly – and estimated to be worth $8.7bn. Now it is estimated to be worth more than $20bn – and growing.
This growth is driven by a market need for portable diagnostic tests that can be performed outside of the laboratory – giving lab-quality results in minutes.
Before the pandemic, an estimated 2bn lateral flow tests were sold each year. This figure has now doubled.
Sectors using lateral flow testing
Food & Drink
Medical & Pharma
Drugs of Abuse
Transform® is as essential to the lateral flow test market as ink suppliers are to the home and office printer market. We give our partners the means to comply with emerging regulation, and transform their offer from single-use tests to data-generating powerhouses.
Total addressable market
We believe we have the potential to partner with up to 54 lateral flow test providers currently.